TOKYO, Feb 13, 2026 – (JCN Newswire) – JCB International Co., Ltd., the international operations subsidiary of JCB Co., Ltd., Japan’s only international payment brand, announces its sponsorship of the NHK Symphony Orchestra Singapore Concert 2026, to be held on April 29, 2026, at the Esplanade Concert Hall in Singapore.
Making the 60th anniversary of diplomatic relations between Japan and Singapore, this special concert will feature the NHK Symphony Orchestra, one of Japan’s leading orchestras, in its first performance in Singapore in 24 years. The program includes works by prominent Japanese composer Yuzo Toyama, together with Benjamin Britten’s Four Sea Interludes from Peter Grimes, a selection inspired by the theme of the “sea” that connects Japan and Singapore, promising a richly varied and compelling musical experience.
Takumi Takahashi, Executive Vice President, JCB International Co. Ltd. said: “We are truly delighted to support the NHK Symphony Orchestra’s concert, presented by one of Japan’s most renowned and distinguished orchestras. This year marks the 60th anniversary of the establishment of diplomatic relations between Japan and Singapore, and the concert we are sponsoring is a special event commemorating this milestone. Through this sponsorship and various other initiatives, we hope to help make the SJ60 celebration even more vibrant.”
Concert Details
Organizer
NHK Symphony Orchestra
Date
April 29, 2026
Venue
Esplanade – Theatres on the Bay, Concert Hall (Singapore)
JCB is a major global payment brand and a leading credit card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. Its acceptance network includes about 71 million merchants around the world. JCB Cards are now issued mainly in Asian countries and territories, with more than 175 million cardmembers. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase its merchant coverage and cardmember base. As a comprehensive payment solution provider, JCB commits to providing responsive and high-quality service and products to all customers worldwide. For more information, please visit: www.global.jcb/en/
Contact
Anna Takeda
Corporate Communications
Tel: +81-3-5778-8353
Email: jcb-pr@info.jcb.co.jp
TOKYO//SINGAPORE, Feb 9, 2026 – (JCN Newswire) – JCB International Co., Ltd., the international operations subsidiary of JCB Co., Ltd., Japan’s only international payment brand, today announced a new collaboration with RESORTS WORLD AT SENTOSA PTE. LTD. (RWS), targeted at Japanese tourists. The partnership with RWS is designed to enhance the travel experience for Japanese visitors to Singapore.
Located on Sentosa, Singapore’s premier resort island, Resorts World Sentosa is one of the nation’s leading integrated lifestyle destinations, welcoming millions of local and international visitors annually across its attractions, dining, entertainment and lifestyle offerings. This collaboration aims to curate meaningful experiences that enhance every stage of the visitor journey for Japanese guests.
JCB and RWS today launched exclusive privileges for Japan-issued JCB cardmembers visiting Singapore’s leading integrated resort. Under this collaboration, eligible JCB cardmembers booking online will enjoy:
1. Up to 20% savings on selected attractions and accommodation experiences; and
2. Dining and retail privileges at participating outlets within RWS attractions.
These privileges are designed to enhance every stage of the visit, from iconic attractions to hotel stay, delivering seamless, rewarding experiences for international guests. Full details, as well as terms and conditions including participating outlets are available on https://www.rwsentosa.com/en/promotions/jcb.
“Our launch of this programme comes at an opportune time, amid a steady rise in Japanese tourist arrivals to Singapore. Visitor numbers from Japan in 2025 have exceeded 2024 while remaining below pre-pandemic levels. Through collaboration with leading attractions such as RWS, we aim to offer Japanese travellers more compelling reasons to visit, enjoy, and extend their stay in Singapore,” said Hiroko Michishita, Managing Director, JCB International Asia Pacific.
Jenny Wang, Acting Senior Vice President, Resort Sales and Marketing, RWS, commented: “We are pleased to partner with JCB to deepen our engagement with Japanese travellers and strengthen RWS’s presence in the Japan market. Through this collaboration, we aim to welcome JCB cardmembers to experience Singapore and RWS through a curated range of attractions, dining and lifestyle experiences, complemented by exclusive privileges and joint marketing initiatives between two trusted brands. Beyond this campaign, our partnership with JCB reflects our longer-term commitment to building sustained relevance in Japan, positioning Resorts World Sentosa as Asia’s leading lifestyle destination that continues to inspire repeat visitation, deeper engagement and enduring brand affinity among Japanese guests.”
JCB is a major global payment brand and a leading credit card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. Its acceptance network includes about 71 million merchants around the world. JCB Cards are now issued mainly in Asian countries and territories, with more than 175 million cardmembers. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase its merchant coverage and cardmember base. As a comprehensive payment solution provider, JCB commits to providing responsive and high-quality service and products to all customers worldwide. For more information, please visit: http://www.global.jcb/en/
Contact
Anna Takeda
Corporate Communications
Tel: +81-3-5778-8353
Email: jcb-pr@info.jcb.co.jp
Special Exhibition Confirmed for Hit Anime “Tensura,” with Second Film Set to Release This Winter!
TOKYO, Feb 9, 2026 – (JCN Newswire) – Anime Tokyo Station is an anime exhibition site focused on Japanese anime content, which has developed a devout fan base around the world. The facility attracts visitors of all ages and has welcomed 253,236 guests from Japan and overseas (as of January 18, 2026).
Anime Tokyo Station regularly hosts special exhibitions for popular anime. From February 21 (Sat.) to May 24 (Sun.), 2026, it will hold the “That Time I Got Reincarnated as a Slime” Special Exhibition.
This popular TV anime first aired in 2018 and has now reached its third season. The story follows Satoru Mikami, an office worker who is suddenly reincarnated as a slime in another world after being caught up in an incident. Taking on the name Rimuru Tempest, he embarks on a series of adventures in this new realm. At present, in addition to the fourth season of the TV anime that is slated to air, a second theatrical release, “That Time I Got Reincarnated as a Slime: The Movie – Tears of the Azure Sea,” is also scheduled for release this February.
This special exhibition will look back on the story through the third season of the TV anime, featuring life-size character panels, character introductions, and a mosaic depicting the scene where Rimuru and Veldora become friends, created using stills from the anime. Visitors can also enjoy interactive digital content, creating an experience unique to Anime Tokyo Station where they can fully immerse themselves in the world of the series.
Come to Anime Tokyo Station and experience what the “That Time I Got Reincarnated as a Slime” Special Exhibition has to offer.
“That Time I Got Reincarnated as a Slime” Special Exhibition
Exhibition Overview
The TV anime “That Time I Got Reincarnated as a Slime” first aired in 2018 and has grown into a beloved series spanning three seasons, with a fourth season slated to air. Additionally, “That Time I Got Reincarnated as a Slime: The Movie – Tears of the Azure Sea” is scheduled for release as well. This special exhibition will feature exhibits that allow visitors to experience the world of the series, including recreations of iconic scenes such as when Rimuru and Veldora become friends, as well as introductions to popular characters.
Highlights of the Exhibition
Exhibits
Life-size character panels
A mosaic depicting the scene where Rimuru and Veldora become friends, created using stills from the anime
A look back at the story through stills and memorable lines
Hands-on areas
AR photo spot: Take a commemorative photo with Rimuru!
And more
What is “That Time I Got Reincarnated as a Slime”?
“That Time I Got Reincarnated as a Slime” is an isekai anime series following a protagonist who is reincarnated as a slime in another world, using the skills he acquires along with his wits and courage to gather allies. The first season of the TV anime aired on TOKYO MX and other channels from October 2018 to March 2019.
In 2021, TV anime Season 2 Part 1 aired from January to March, followed by the spin-off comic adaptation “Slime Diaries: That Time I Got Reincarnated as a Slime” from April to June, and TV anime Season 2 Part 2 from July to September, making for nine consecutive months of broadcasts. Then, on November 25, 2022, “That Time I Got Reincarnated as a Slime: The Movie – Scarlet Bond” was released nationwide, becoming a major hit with over one million admissions and box office revenue of 1.4 billion yen in Japan.
To commemorate the 10th anniversary of the web novel “That Time I Got Reincarnated as a Slime,” the Tensura 10th Project launched on February 20, 2023. As part of this project, the all-new three-episode animation “That Time I Got Reincarnated as a Slime: Visions of Coleus” began streaming on November 1, 2023. On December 16, 2023, the series’ first large-scale event, That Time I Got Reincarnated as a Slime: Tensura 10th Live, was held at Mori no Hall 21 in Matsudo. Furthermore, the third season of the TV anime aired from April to September 2024. Following the final episode of Season 3, production of a second theatrical film and Season 4 of the TV anime was announced. “That Time I Got Reincarnated as a Slime: The Movie – Tears of the Azure Sea” is set to release on February 27, 2026.
The original manga “That Time I Got Reincarnated as a Slime” (serialized in Kodansha’s Monthly Shonen Sirius / Manga: Taiki Kawakami, Original story: Fuse, Character design: Mitz Vah) is a comic adaptation of the popular web novel of the same name by Fuse, which surpassed 1 billion page views on the user-generated novel publishing website “Shosetsuka ni Naro.” The combined worldwide circulation of the manga, novels, and spin-off works has exceeded 56 million copies (as of June 2025).
* “Shosetsuka ni Naro” is a registered trademark of HinaProject Inc.
Tensura Portal Site: ten-sura.com
Official X: @ten_sura_anime / Official Instagram: tensura_official / Official TikTok: @ten_sura_anime
Venue Overview
Name:
Anime Tokyo Station (also known as “Anime Tokyo”)
Location:
Floors B1 to 2F of Tokyu East 5 (2-25-5 Minami-Ikebukuro, Toshima-ku, Tokyo)
*4 minutes on foot from Ikebukuro Station
Hours:
11:00 a.m. to 7:00 p.m. (last admission: 6:45 p.m. / Special exhibitions close: 6:30 p.m.)
Closed:
Mondays
*If Monday falls on a holiday, the venue will be open on Monday and closed on the following day
New Year’s holiday period
May be closed on other days
Please check the venue website before coming.
Inquiries regarding this press release
Public Relations Office of “Anime Tokyo Station” (Kyodo PR)
Contact person: Miri Yasuda
E-mail: animetokyo-pr@kyodo-pr.co.jp
Expanding production capacity by introducing automated equipment reduces manufacturing costs and shortens delivery times
TOKYO, Feb 5, 2026 – (JCN Newswire) – TANAKA PRECIOUS METAL TECHNOLOGIES Co., Ltd. (Head Office: Chuo-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), a company engaged in the industrial precious metals business of TANAKA, announced today that it has established a total solution system capable of supporting all processes in the contract manufacturing business for various test kits including in vitro diagnostics.
Until now, TANAKA has been responsible primarily for processes from developing and manufacturing test kits to bulk production of extraction buffer. At this time, TANAKA established dedicated production lines for the dispensing and packaging of extraction buffer, creating a system that enables it to complete all processes in-house from development to manufacture of final products. This enables TANAKA to reduce costs and the time for external outsourcing and transportation, making it possible to deliver high-quality products in shorter times.
In addition, TANAKA will seek to expand production capacity and shorten lead times even further by introducing additional state-of-the-art automatic assembly lines and extract dispensing equipment with a target of March 2026.
TANAKA’s Total Solution System
Flexible responses achieved through reinforced integrated production system
By establishing this total solution system, TANAKA will be able to provide comprehensive contract services covering all processes from test kit development and manufacturing to bulk production, dispensing, and packaging of extraction buffer. This will enable TANAKA to continuously support customers from the development stage through mass production while also accommodating request for individual processes such as extraction buffer dispensing only.
By bringing production processes entirely in-house, TANAKA will further reinforce stable supply and quality control.
A track record in the development of diagnostic test kits across a wide range of disease areas and examples of deployment
TANAKA offers in vitro diagnostics for a wide range of infectious diseases including respiratory tract infections, such as influenza and COVID-19, as well as dengue and ZIKA viruses. These test kits are compatible with various sample types such as saliva, blood, and urine, and support rapid and accurate testing in clinical settings.
Respiratory Tract Infections
Mosquito-Born Infectious Diseases
Obstetrics
・ Influenza virus
・ Adenovirus
・ RS virus
・ Human meta-virus
・ COVID-19
・Group A beta hemolytic Streptococcus (Streptococcus pyogenes)
・ Dengue virus
・ Zika virus
・ Chikungunya virus
・ Pregnancy testing
Examples of Disease Areas That TANAKA Deploys Tests For
Technical foundations and future outlook
TANAKA started research and development of in vitro diagnostics around 2006 and has accumulated technologies centered on nano-colloidal gold (Au). It possesses a diverse range of technologies that support the enhancement of reagent performance using immunochromatographic assay, including protein immobilization technology, non-specific absorption expression technology, and antigen-antibody reaction enhancement technology, TANAKA provides contract manufacturing of high-quality test kits that leverage these technologies in accordance with the ISO 13485 system.
Going forward, TANAKA will leverage this total solution system to develop new diagnostics in collaboration with partner companies, while contributing to solutions to social issues and advancement of the field of medicine.
About TANAKA
Since its foundation in 1885, TANAKA has built a portfolio of products to support a diversified range of business uses focused on precious metals. TANAKA is a leader in Japan regarding the volume of precious metals it handles. Over many years, TANAKA has manufactured and sold precious metal products for industry and provided precious metals in such forms as jewelry and assets. As precious metals specialists, all Group companies in Japan and worldwide collaborate on manufacturing, sales, and technology development to offer a full range of products and services. With 5,591 employees, the group’s consolidated net sales for the fiscal year ended December 2024 were 846.9 billion yen.
ANY EXPRESS WRITTEN WARRANTY THAT TANAKA MAY ISSUE, IS THE SOLE AND EXCLUSIVE WARRANTY AS TO TANAKA’S MATERIALS AND PRODUCTS, EXTENDS ONLY TO THE INITIAL PURCHASER FROM TANAKA OR ITS AUTHORIZED DISTRIBUTOR, IS NOT TRANSFERABLE OR ASSIGNABLE, AND IS EXPRESSLY IN LIEU OF AND TANAKA EXPRESSLY DISCLAIMS TO THE EXTENT PERMISSIBLE UNDER APPLICABLE LAW ANY OTHER WARRANTY, ORAL OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY ORAL OR IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR PARTICULAR PURPOSE.
TANAKA SHALL NOT BE LIABLE FOR ANY INCIDENTAL, SPECIAL, OR CONSEQUENTIAL LOSS, DAMAGE, OR EXPENSE (INCLUDING, WITHOUT LIMITATION, LOST PROFITS) DIRECTLY OR INDIRECTLY ARISING FROM THE SALE, INABILITY TO SELL, USE, OR LOSS OF USE OF ANY PRODUCT. NO ORAL OR WRITTEN INFORMATION OR ADVICE GIVEN BY TANAKA, ITS EMPLOYEES, DISTRIBUTORS, DEALERS, OR AGENTS SHALL INCREASE THE SCOPE OF ANY WARRANTY OR CREATE ANY NEW WARRANTIES.
THE LIMITATIONS AS STATED HEREIN SHALL NOT PRECLUDE ANY LIABILITY WHICH UNDER APPLICABLE PRODUCTS LIABILITY LAW CANNOT LEGALLY BE PRECLUDED BY CONTRACT OR OTHERWISE.
NEVER USE THIS TEST KIT AS THE ONLY GUIDE TO MANAGE YOUR CONDITION OR ILLNESS. CONSULT YOUR HEALTHCARE PROVIDER IF YOUR SYMPTOMS PERSIST OR BECOME MORE SEVERE, OR IF YOU ARE CONCERNED AT ANY TIME.
Cloud-based AI application for colorectal cancer prevention: Enhancing detection of clinically significant lesions without compromising safety and workflow efficiency
TOKYO, Feb 3, 2026 – (JCN Newswire) – Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced publication of the EAGLE Trial1 — a multicenter randomized controlled study evaluating the CADDIE™ device, the first cloud-based Computer-Aided Detection (CADe) application for real-time polyp detection during colonoscopy that is both FDA-cleared and CE-marked. The CADDIE software is the first solution introduced as part of the OLYSENSE™ Intelligent Endoscopy Ecosystem.
The cloud-based CADDIE™ device for computer-aided detection indicates a potential polyp during a colonoscopy procedure.
The trial indicates that cloud-deployed AI can help endoscopists detect the lesions that matter most in preventing progression to cancer2–5 — large adenomas, particularly those flat in morphology, and sessile serrated lesions (SSLs) — without disrupting safety or workflow. The study has been published in npj Digital Medicine.1
EAGLE Trial Overview
The EAGLE (Evaluation of AI for detection of Gastrointestinal Lesions in Endoscopy) study was conducted across eight centers in four European countries6, and its primary analysis involved 841 patients and 22 endoscopists performing screening and surveillance colonoscopies. Patients were randomized to standard colonoscopy or CADDIE-assisted colonoscopy.
Key Findings
Improved detection of high-risk and hard-to-detect lesions
In screening and surveillance patients, use of the CADDIE™ application was associated in this study with 7.3% absolute increase in adenoma detection rate (ADR), compared to standard colonoscopy. Moreover, significant relative increases in lesions detected per colonoscopy were observed in this study for clinically relevant lesion subtypes: 93% for large (>10 mm) adenomas, 57% for non-polyploid adenomas and 230% for SSLs.
Feasible and efficient real-time cloud-based deployment
The system demonstrated real-time performance and operational efficiency across diverse testing environments.
Clinically Relevant by Design
The CADDIE™ application is trained on a dataset enriched in clinically relevant and hard-to-detect lesions, including flat sessile serrated lesions (SSLs) and large polyps (≥10 mm).
Lesions with sessile or flat morphology are difficult to detect and can harbor clinically relevant pathology. SSLs, in particular, are high-risk lesions whose detection is critical to reducing the risk of post-colonoscopy colorectal cancer3–4. The ability to reliably detect SSLs is increasingly viewed as a critical quality consideration in colonoscopy7. This study demonstrates increased detection of clinically relevant lesions and no increase in unnecessary resections, addressing some of the concerns raised in recent guidelines8–9.
Why Cloud Matters?
The CADDIE™ application leverages a cloud architecture that uses industry standard security controls. Cloud deployment offers hospitals flexibility, reducing reliance on hardware and enabling subscription-based procurement models. This approach can democratize access to advanced AI tools and lays the foundation for future AI applications in endoscopy.
Expert Perspectives
“This study marks a pivotal shift in the clinical translation of AI-assisted endoscopy,” said Rawen Kader, Principal Investigator of the EAGLE Trial and GI Researcher at University College London. “Cloud deployment can remove hardware barriers and give hospitals access to the latest AI innovations, which has the potential of improving detection of the lesions that matter most for reducing colorectal cancer risk.”
“The publication of EAGLE study in a high-impact journal like npj Digital Medicine is a pivotal moment for Olympus, supporting clinical adoption of the CADDIE™ device as an AI solution that can enhance detection of clinically relevant lesions without compromising safety or efficiency,” said Miquel Àngel García, Executive Vice President and General Manager, Gastrointestinal Business Unit, Olympus Corporation.
“The EAGLE trial demonstrates how cloud‑based AI can be translated into routine endoscopy at scale,” said Peter Mountney, CEO of Odin Vision and Vice President, AI Unit, Olympus Corporation. “By delivering AI in real time through the cloud, we can help accelerate innovation and enable hospitals around the world to benefit from our latest, evidence‑based technologies to support clinicians and enhance the quality of care.”
The gastroenterologist is responsible for reviewing CADDIE suspected polyp areas and confirming the presence or absence of a polyp based on their own medical judgment.
CADDIE is not intended to replace a full patient evaluation, nor is it intended to be relied upon to make a primary interpretation of endoscopic procedures, medical diagnosis, or recommendations of treatment/course of action for patients. The CADDIE computer-assisted detection device is limited for use with standard white-light endoscopy imaging only.
1. Kader R, Hassan C, Lanas Á, et al. A novel cloud-based artificial intelligence for real-time detection of colorectal neoplasia – a randomized controlled trial (EAGLE). npj Digit.l Med.. Published online December 26, 2025. https://doi.org/10.1038/s41746-025-02270-1 2. Nguyen LH, Goel A, Chung DC. Pathways of Colorectal Carcinogenesis. Gastroenterology. 2020;158(2):291-302. doi:10.1053/j.gastro.2019.08.059 3. Anderson JC, Hisey W, Mackenzie TA, et al. Clinically significant serrated polyp detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry. Gastrointest Endosc. 2022;96(2):310-317. doi:10.1016/j.gie.2022.03.001 4. Toledo DEFWMv, IJspeert JEG, Bossuyt PMM, et al. Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study. Lancet Gastroenterol Hepatol. 2022;7(8):747-754. doi:10.1016/s2468-1253(22)00090-5 5. Soetikno RM. Prevalence of Nonpolypoid (Flat and Depressed) Colorectal Neoplasms in Asymptomatic and Symptomatic Adults. JAMA. 2008;299(9):1027. doi:10.1001/jama.299.9.1027 6. Italy, Germany, Spain, Poland 7. Rex DK, Anderson JC, Butterly LF, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2024;100(3):352-381. doi:10.1016/j.gie.2024.04.2905 8. Bretthauer M, Ahmed J, Antonelli G, et al. Use of computer-assisted detection (CADe) colonoscopy in colorectal cancer screening and surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. Published online 2025:. doi:10.1055/a-2543-0370 9. Sultan S, Shung DL, Kolb JM, et al. AGA Living Clinical Practice Guideline on Computer-Aided Detection–Assisted Colonoscopy. Gastroenterology. 2025;168(4):691-700. doi:10.1053/j.gastro.2025.01.002
About Olympus
At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit olympus-global.com and follow us on LinkedIn.
TOKYO, Feb 2, 2026 – (JCN Newswire) – JCB Co., Ltd. (Headquarters: Minato-ku, Tokyo; Chairman & Chief Executive Officer: Takayoshi Futae; hereinafter: JCB) today announced a promotion campaign for inbound visitors to Japan in the Tenjin area of Fukuoka City, running from February 2 to March 31, 2026. As part of the ongoing business partnership between JCB and American Express in Japan, the campaign is also available to eligible overseas American Express Card Members, including those holding American Express cards issued through partner institutions.
JCB and American Express have previously collaborated on initiatives supporting shopping districts and local retailers. In 2025, the two companies conducted a campaign in Kobe City to promote inbound tourism. Building on that success, the new Tenjin campaign invites international visitors to enjoy shopping at participating department stores and retailers popular with tourists.
During the campaign period, cardmembers who make a single purchase of 5,000 JPY or more (including tax) using an overseas-issued JCB or American Express card at participating merchants will receive an original Japanese-style drawstring pouch. Prize redemption will be available at an event space directly connected to Tenjin Station, with banners and roll-up displays creating a lively atmosphere. Campaign awareness will further be amplified through announcements on Tenjin Station’s large-screen displays and at nearby hotels, encourage shopping.
JCB is a major global payment brand and a leading credit card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. Its acceptance network includes about 71 million merchants around the world. JCB Cards are now issued mainly in Asian countries and territories, with more than 175 million cardmembers. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase its merchant coverage and cardmember base. As a comprehensive payment solution provider, JCB commits to providing responsive and high-quality service and products to all customers worldwide. For more information, please visit: www.global.jcb/en/
Contact
Anna Takeda
Corporate Communications
Tel: +81-3-5778-8353
Email: jcb-pr@info.jcb.co.jp
TOKYO, Jan 30, 2026 – (JCN Newswire) – Anime Tokyo Station (2-25-5 Minami-Ikebukuro, Toshima-ku, Tokyo) is an anime exhibition facility dedicated to Japanese anime content, which has developed a passionate fan base both in Japan and abroad. Since its opening, the venue welcomed over 250,000 visitors from around the world.
Led by the concept of rediscovering the appeal of anime, Anime Tokyo Station has expanded its presence to Roblox, one of the world’s leading immersive platforms, through the release of ANIME TOKYO STATION ON ROBLOX, a hub with interactive games that allow players to explore the charm of Japanese anime and the world of Anime Tokyo Station itself. This Roblox hub has already been visited by over 630,000 players. To commemorate the hub’s one-year anniversary, Anime Tokyo Station will be making various updates and giving out free gifts. In addition to giving out free “Shoulder-Perched Cat Train Conductors” that players can use to customize their avatars, the ANIME☆OTODAMA game will be expanded with a new “Momotaro” scenario and the ANIME☆SKILL TCG will be getting new cards, a new ADR timing minigame, and a new undersea passage area. Furthermore, Anime Tokyo Station will also be giving out in-game badges to commemorate the 1st anniversary of the hub’s release and, in conjunction with this badge give-away, it will also be handing out exclusive gifts in the real-world Anime Tokyo Station.
Please take this opportunity to enjoy Anime Tokyo Station in both the metaverse and the real world.
For more information on how to play the game and upcoming version updates, please visit the ANIME TOKYO STATION ON ROBLOX special page within the Anime Tokyo Station website.
(1) The first 2,000 people to complete the mission will receive “Shoulder-Perched Cat Train Conductors” (free UGC)
The first 2,000 players to complete the mission that unlocks at 10:00 a.m. on Friday, January 30, 2026 will receive free UGC that they can use to customize their player visuals!
Perch this cute cat train conductor that welcomes visitors to ANIME TOKYO STATION ON ROBLOX on your avatar’s shoulder.
(2) Momotaro is coming to ANIME☆OTODAMA, along with a new shop!
Momotaro, a superhero from the world of Japanese fairy tales, is coming to the world of ANIME☆OTODAMA. Collect the special otodamas to unlock the dog, monkey, pheasant, and ogre of the Momotaro story. Enjoy watching the kind of spectacle you can only expect from Anime Tokyo Station, a facility dedicated to showcasing the appeal of anime.
Two ANIME☆SKILL TCG shops will also be opening up: Kinema Club and Anime TAIZEN. Here, you can buy items to make the game even more fun.
(3) A new minigame, map, and skill cards in ANIME☆SKILL TCG
New skill cards and character cards will be added to ANIME☆SKILL TCG, which launched last November. Now players can have even more fun in the world of anime production. There will also be a new minigame, the ADR Timing Game, where players can collect the coins they’ll need to get new cards. The map will feature a new undersea passage, creating an even larger game world for players to explore.
ADR Timing Game
How to play:
Tap when the 〇 and 〇 line up! If your ADR is successful, your score will rise. Shoot for a high score to collect special cards and coins!
(4) All players will receive a commemorative badge celebrating the one-year anniversary!
Everyone who visits ANIME TOKYO STATION ON ROBLOX will receive a commemorative badge to celebrate the hub’s one-year anniversary. These badges will only be given out until March 31, so make sure to come by and get one.
(5) Free pouches will be given out at the real-world Anime Tokyo Station
Visitors to the real-world Anime Tokyo Station, located in Ikebukuro, Tokyo, will receive exclusive pouches when they present a one-year anniversary commemorative badge that they received in-game in (4).
Pouches will be given out until Tuesday, March 31, but supplies are limited. Take this opportunity to visit Anime Tokyo Station in person and get one before they’re all gone.
Information on Version Updates and Release Campaigns
For information on gift campaigns within Roblox and upcoming version updates, please visit the official website and official X account.
Special website page: https://animetokyo.jp/en/roblox/
Official X account: https://x.com/animetokyo_info (@animetokyo_info)
What is Roblox?
As of the end of December 2024, Roblox is the world’s fastest-growing immersive social platform. It is available in 190 countries and 16 languages, and has roughly 90 million daily active users (as of November 2024). It is particularly popular with young people. Users spend an average of 2.4 hours a day in Roblox, and total play time is on the rise, increasing 24% year-on-year. In Roblox, users can enjoy both gaming and social features. It is particularly popular in the U.S. and Canada, and in Asia, is rapidly growing in Japan and India. Its Japanese user base has grown 56% year-on-year. Roblox is also starting to be used for education, business, and community revitalization, and expectations are high for its continued future expansion.
Venue Overview
Name:
Anime Tokyo Station (also known as “Anime Tokyo”)
Location:
Floors B1 to 2F of Tokyu East 5 (2-25-5 Minami-Ikebukuro, Toshima-ku, Tokyo)
*4 minutes on foot from Ikebukuro Station
Hours:
11:00 a.m. to 7:00 p.m. (last admission: 6:45 p.m. last admission for special exhibitions: 6:30 p.m.)
Closed:
Mondays
*If Monday falls on a holiday, the venue will be open on Monday and closed on the following day
New Year’s holiday period
May be closed on other days
Please check the venue website before coming.
Inquiries regarding this press release
Public Relations Office of “Anime Tokyo Station” (Kyodo PR)
Contact person: Miri Yasuda
E-mail: animetokyo-pr@kyodo-pr.co.jp
Recognition highlights employee participatory health promotion initiatives and support for and advocacy of parasports
TOKYO, Jan 28, 2026 – (JCN Newswire) – TANAKA PRECIOUS METAL GROUP Co., Ltd. (Head office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) announces that it has been recognized as a Tokyo Sports Promotion Company for fiscal 2025 under the certification program administered by the Tokyo Metropolitan Government. This marks the 11th consecutive year of recognition for the Group, following its initial certification in fiscal 2015.
The Tokyo Sports Promotion Company Certification System was established by the Tokyo Metropolitan Government in fiscal 2015, under which companies and organizations that actively promote employees’ participation in sports and engage in social contribution activities related to sports are certified as Tokyo Sports Promotion Companies. In fiscal 2025, 427 companies in Japan received certification, bringing the total number of certified companies to 656.
At TANAKA, in addition to initiatives aimed at promoting employee health and enhancing internal communication, the Group is engaged in supporting the promotion of sports as part of its commitment to contributing to the realization of an inclusive society and the creation of a healthy society.
Externally, TANAKA continues its sponsorship activities as an official partner of the Japan Blind Football Association (JBFA). The Group also served as a category sponsor for awards and ceremonies at the LIGA.i Blind Soccer Top League 2025. Through these initiatives, TANAKA supports the wider adoption and development of sports while working to deepen understanding of parasports and to promote a society that respects diversity.
In addition, as part of health promotion measures for employees and their families, TANAKA implemented the “TANAKA Health Challenge 2025.” This employee participatory initiative allows participants to select from multiple health and exercise-related challenge items that can be incorporated into daily life according to individual lifestyles, and to work on them over a designated period. The program focuses primarily on activities such as walking and stretching, which help address a lack of physical activity and improve lifestyle habits, thereby encouraging greater health awareness and positive behavioral change. Through these efforts, TANAKA contributes to the prevention of lifestyle-related diseases and the maintenance of both physical and mental health.
These ongoing initiatives have been recognized, leading to the Group’s certification for the 11th consecutive year.
TANAKA will continue its efforts to promote health through sports and to engage in social contribution activities on an ongoing basis.
About TANAKA
Since its foundation in 1885, TANAKA has built a portfolio of products to support a diversified range of business uses focused on precious metals. TANAKA is a leader in Japan regarding the volume of precious metals it handles. Over many years, TANAKA has manufactured and sold precious metal products for industry and provided precious metals in such forms as jewelry and assets. As precious metals specialists, all Group companies in Japan and worldwide collaborate on manufacturing, sales, and technology development to offer a full range of products and services. With 5,591 employees, the group’s consolidated net sales for the fiscal year ended December 2024 were 846.9 billion yen.
TANAKA will showcase platinum- and other precious metal-based materials, backed by 140 years of expertise, advanced processing technologies, and a stable global supply system
TOKYO, Jan 21, 2026 – (JCN Newswire) – TANAKA PRECIOUS METAL TECHNOLOGIES Co., Ltd., a leading global manufacturer of precious metal materials, will exhibit its Visi Fine® Series, a lineup of highly radiopaque precious metal materials and other precious metal-based materials for medical device components, at MD&M West 2026, to be held February 3–5, 2026, at the Anaheim Convention Center in Anaheim, California.
First unveiled at the 2025 event, the Visi Fine® portfolio harnesses TANAKA’s deep expertise in materials development and advanced processing technologies—including diverse melting methods, ultra-fine wire manufacturing, and laser processing—to transform precious metals into highly reliable materials for medical device components. The Visi Fine® brand name is a coined term combining “Visi” (visibility) and “Fine” (ultra-fine, refined materials). It embodies the concept of delivering materials with excellent radiopacity, engineered through advanced processing technologies for use in highly reliable medical device components. By leveraging the high density, superior radiopacity, and strong resistance to oxidation and corrosion of precious metals such as gold and platinum, Visi Fine® materials are particularly well suited for high-precision, minimally invasive medical devices.
“Minimally invasive surgeries and treatments have become a cornerstone of modern clinical practice,” said Yasutaka IHARA, Director & Corporate Officer, TANAKA. “Smaller devices such as catheters, implantable products, and diagnostic and therapeutic systems require meticulous precision while remaining clearly visible under X-ray imaging to ensure effective care. Already utilized globally, the Visi Fine® series delivers exceptional reliability, customization, biocompatibility, radiopacity, and corrosion resistance, supporting the development of next-generation, high-precision medical devices.”
To achieve these high standards, medical device manufacturers rely on premium materials from trusted suppliers. As the largest precious metals manufacturer in Asia, TANAKA combines regional leadership with a robust global presence, ensuring rapid support both domestically and internationally. With a 140-year history, TANAKA offers a comprehensive, end-to-end service model encompassing bullion procurement, materials processing and manufacturing, product sales, and recycling. This integrated approach enables medical device manufacturers to streamline supply chains, ensure material quality and traceability, and support sustainability initiatives through precious metal recovery and reuse.
Through its participation in MD&M West 2026, TANAKA reaffirms its commitment to supporting innovation in the medical and healthcare industries by supplying advanced precious metal materials backed by technical expertise, manufacturing excellence, and a resilient global supply network.
Main Exhibited Products
The main products on display at MD&M West will include precious metal materials and precision-processed components used in a wide range of medical device applications, particularly catheter-based and implantable devices that require high reliability, biocompatibility, corrosion resistance, and radiopacity.
TANAKA offers the Visi Fine® series, a lineup of highly reliable platinum-based fine wire materials that deliver excellent radiopacity, corrosion resistance, and mechanical stability, making them well suited for medical device components such as marker bands, electrodes, and implantable parts. By leveraging advanced wire drawing and processing technologies, TANAKA provides fine wires with tight dimensional control and consistent quality, supporting demanding medical applications.
Market Bands and EP Bands
– Marker Bands and EP Bands
Marker bands are essential components for enhancing visibility under X-ray imaging in catheter-based medical devices, supporting accurate device positioning during medical procedures. TANAKA manufactures marker bands from smooth-surface tubing, produced through the careful selection of high-purity materials and optimized manufacturing processes to ensure excellent uniformity, durability, and radiopacity.
Solid marker bands are available in a range of materials, including Pt (99.95%), PtIr10, and other precious metal alloys, designed to meet stringent medical device performance requirements. In addition, split marker bands are offered to provide greater design flexibility, enabling customized configurations tailored to specific device architectures and functional needs. All marker bands are manufactured under an ISO 13485–certified quality management system, ensuring consistent quality, reliability, and regulatory compliance.
Micromachining Components: Using Laser Cutting and Precision Micromachining Technology
– Micromachining components
TANAKA offers precious metal micromachined components for medical device applications, including cardiovascular and peripheral vascular treatments. By leveraging advanced processing technologies, such as precision machining, femtosecond laser processing, stamping, and welding, TANAKA produces complex-shaped components with excellent burr control and clean surface finishes. A broad range of precious metal materials—including Pt, Pt-Ir, Pt-Ni, and Pt-W alloys—supports high-precision designs that meet the stringent performance and reliability requirements of medical devices.
Rhodium sheets are specifically designed for mammography filter applications. With a controlled thickness of 0.05 mm, these rhodium sheets feature a smooth, crack-free surface and excellent thickness uniformity. By leveraging its expertise in high-purity precious metal refining and advanced materials processing, TANAKA delivers rhodium sheets with the quality and consistency required for reliable performance in mammography imaging systems.
MD&M West 2026 Outline – Title: MD&M West 2026 – Dates and Times: February 3–5, 2026 (local time, Pacific Standard Time) – Location: Anaheim Convention Center (Anaheim, California, USA) – Website:https://www.mdmwest.com – Exhibitor: TANAKA PRECIOUS METAL TECHNOLOGIES Co., Ltd. – Booth No.: 2185
– TANAKA will exhibit a range of precious metal materials and components for medical device applications, including Platinum (Pt) wire, Gold (Au) wire, Platinum marker bands, Platinum–Iridium (PtIr) marker bands, Split marker bands, Micromachining components, and Rhodium (Rh) sheet (Product images and detailed technical information will be available at the booth.)
About TANAKA
Since its foundation in 1885, TANAKA has built a portfolio of products to support a diversified range of business uses focused on precious metals. TANAKA is a leader in Japan regarding the volume of precious metals it handles. Over many years, TANAKA has manufactured and sold precious metal products for industry and provided precious metals in such forms as jewelry and assets. As precious metals specialists, all Group companies in Japan and worldwide collaborate on manufacturing, sales, and technology development to offer a full range of products and services. With 5,591 employees, the group’s consolidated net sales for the fiscal year ended December 2024 were 846.9 billion yen.
ANY EXPRESS WRITTEN WARRANTY THAT TANAKA MAY ISSUE, IS THE SOLE AND EXCLUSIVE WARRANTY AS TO TANAKA’S MATERIALS AND PRODUCTS, EXTENDS ONLY TO THE INITIAL PURCHASER FROM TANAKA OR ITS AUTHORIZED DISTRIBUTOR, IS NOT TRANSFERABLE OR ASSIGNABLE, AND IS EXPRESSLY IN LIEU OF AND TANAKA EXPRESSLY DISCLAIMS TO THE EXTENT PERMISSIBLE UNDER APPLICABLE LAW ANY OTHER WARRANTY, ORAL OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY ORAL OR IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR PARTICULAR PURPOSE.
TANAKA SHALL NOT BE LIABLE FOR ANY INCIDENTAL, SPECIAL, OR CONSEQUENTIAL LOSS, DAMAGE, OR EXPENSE (INCLUDING, WITHOUT LIMITATION, LOST PROFITS) DIRECTLY OR INDIRECTLY ARISING FROM THE SALE, INABILITY TO SELL, USE, OR LOSS OF USE OF ANY PRODUCT. NO ORAL OR WRITTEN INFORMATION OR ADVICE GIVEN BY TANAKA, ITS EMPLOYEES, DISTRIBUTORS, DEALERS, OR AGENTS SHALL INCREASE THE SCOPE OF ANY WARRANTY OR CREATE ANY NEW WARRANTIES.
THE LIMITATIONS AS STATED HEREIN SHALL NOT PRECLUDE ANY LIABILITY WHICH UNDER APPLICABLE PRODUCTS LIABILITY LAW CANNOT LEGALLY BE PRECLUDED BY CONTRACT OR OTHERWISE.
The Start of the Precious Fragrance Project, Which Seeks to Express Sensibilities through Fragrance
TOKYO, Jan 7, 2026 – (JCN Newswire) – TANAKA MIRAI Lab., an in-house innovation organization of TANAKA PRECIOUS METAL GROUP Co., Ltd. (head office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka), launched the Precious Fragrance Project in fiscal year 2025 as part of its initiatives in the new “Precious Things” field, where it seeks to create new value.
The first fruit of this project is a new perfume (limited series of 1,000 bottles, not for sale) with a unique fragrance, developed by TANAKA MIRAI Lab., that expresses the essence of gold (Au). Gold has always been a key product for TANAKA, which constantly pursues the rare and exceptional value of precious metals, ever since its foundation.
TANAKA engages in ultra-long-term corporate management that looks to 2085, the 200th anniversary of the Group’s founding, and beyond. TANAKA MIRAI Lab. was created to lead the Group in everything from the creation to the realization of new paradigms. It believes that the rare and exceptional value that will remain through 2085 lies in the domains that make us human, so it is engaged in the pursuit of “Precious Things” that link to the “Embodiment” and “Emotion” uniquely inherent to people.
Precious Fragrance is one of the fruits of its efforts to realize these “Precious Things”. The goal of this project is to embody sensibilities through “fragrance”, which directly acts on the human cerebral limbic system and remains in the form of memories.
In fiscal year 2025, TANAKA began working together with fragrance experts to develop fragrances from the ground up, led by the concept of “Authentic Uniqueness,” derived from the metal that is synonymous with TANAKA: gold (Au). The culmination of these efforts was the perfume “The TANAKA 2025.” Only 1,000 bottles of this perfume, which is not for sale, have been made. They will provide an unparalleled fragrance experience, a signature of the TANAKA brand.
We plan to expand the “Precious Fragrance” collection in the future by focusing on the development of fragrances based on metals such as silver (Ag) and platinum (Pt).
The TANAKA 2025’s fragrance design
The theme of this fragrance is “Radiant Golden Glow,” a noble floral oriental scent, luxuriously composed of vibrant natural rose and elegant natural iris, accented with a chic touch of oud. The moment someone puts it on, the fragrance unfolds with a radiant golden glow, evoking the dazzling brilliance of gold.
Design and appearance
Fragrance was not the only thing lavish attention was paid to—the utmost care was also paid to The TANAKA 2025’s design. The triangular glass bottle is unique, made using newly created molds. The logo’s motif is “田,” the first character in “田中” (“TANAKA”). It is iconic, calling to mind the image of a Japanese family crest. The base colors of the packaging and label are a deep midnight blue and gold, imparting a sense of exceptional grace and discernment.
About TANAKA MIRAI Lab.
TANAKA has been advancing a transformation of its overall business toward the year 2085, the 200th anniversary of its founding, with the aim of “creating a future that no one has ever seen before.” As part of this initiative, TANAKA launched TANAKA MIRAI Lab, an organization to advance this transformation and create the future.
TANAKA MIRAI Lab.’s mission is to envision an unseen future and realize various possibilities by conducting research derived from “kisho (precious and rare) value.”
Since its foundation in 1885, TANAKA has built a portfolio of products to support a diversified range of business uses focused on precious metals. TANAKA is a leader in Japan regarding the volume of precious metals it handles. Over many years, TANAKA has manufactured and sold precious metal products for industry and provided precious metals in such forms as jewelry and assets. As precious metals specialists, all Group companies in Japan and worldwide collaborate on manufacturing, sales, and technology development to offer a full range of products and services. With 5,591 employees, the group’s consolidated net sales for the fiscal year ended December 2024 were 846.9 billion yen.
